NM
Neumora Therapeutics, Inc. Common Stock (NMRA)
NASDAQ·Healthcare·Biotechnology
$2.22
-0.23%
Mkt Cap $409.59M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | — | — | — | -$0.34 | -$0.35 | -2.94% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.34 | -$0.35 | -2.94% | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | -$0.38 | -$0.33 | +13.16% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.40 | -$0.42 | -5.00% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.46 | -$0.37 | +19.57% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.38 | -$0.45 | -18.42% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.37 | -$0.37 | +0.00% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.35 | -$0.34 | +2.86% | — | — |
| Q1 2024 Mar 7, 2024 | — | — | — | -$0.65 | -$0.71 | -9.23% | — | — |
| Q4 2023 Nov 1, 2023 | — | — | — | -$0.36 | -$1.14 | -216.67% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.25 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.23 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.19 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.19 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.20 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.28 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.18 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$1.17 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.11 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.10 | — | — | — |